A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2).
作者信息
Lambdin Jacob, Ryan Carrie, Gregory Stephanie, Cardona Kenneth, Hernandez Jonathan M, van Houdt Winan J, Gronchi Alessandro
机构信息
Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital Midtown, Atlanta, Georgia, USA.
出版信息
Ann Surg Oncol. 2023 Aug;30(8):4573-4575. doi: 10.1245/s10434-023-13500-9. Epub 2023 May 11.
PMID:37170037
Abstract
摘要
相似文献
[1]
[2]
[3]
[Current state of neoadjuvant therapy of soft tissue sarcoma].
Chirurg. 2011-11
[4]
Neoadjuvant Chemotherapy in Retroperitoneal Sarcoma: A National Cohort Study.
Ann Surg Oncol. 2023-10
[5]
Retroperitoneal sarcomas: combined modality treatment approaches.
Curr Opin Oncol. 2002-7
[6]
[7]
Treatment of retroperitoneal sarcoma: current standards and new developments.
Curr Opin Oncol. 2017-7
[8]
[9]
[10]
Management of retroperitoneal soft-tissue sarcoma.
J La State Med Soc. 2004
引用本文的文献
[1]
[2]
[3]
[4]
[5]
[6]
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target.
Int J Mol Sci. 2025-2-25
[7]
[8]
Histology-Tailored Approach to Soft Tissue Sarcoma.
Ann Surg Oncol. 2024-11
本文引用的文献
[1]
[2]
[5]
[6]
[7]
Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management.
Expert Rev Anticancer Ther. 2009-8
Zotero 插件